Intra-arterial Sphenopalatine Ganglion Block for Patients With Refractory Headache | MicrobiomeTrials← Back to trialsNCT04353505
Intra-arterial Sphenopalatine Ganglion Block for Patients With Refractory Headache
WITHDRAWNPHASE1INTERVENTIONAL
Trial Details
Start: 2020-10Est. Completion: 2022-06
Enrollment target: 0 participants Locations- Weill Cornell Medicine, New York, New York, United States
Other microbiome trials you might be interested in
Eye Pain
Approximately 20% of Veterans have a diagnosis of dry eye (DE) syndrome which is often accompanied by ocular pain that s…
Miami, United StatesCompleted Nov 30, 2024
Temporomandibular Disorder
Temporomandibular disorders (TMD) encompass a group of conditions involving the masticatory muscles, temporomandibular j…
Ridgeland, United StatesEst. completion Jan 1, 2027
Smokers With Chronic Pain
The purpose of this study is to understand whether psilocybin therapy is safe and well tolerated in improving chronic pa…
West Haven, United StatesEst. completion Oct 1, 2027